Clinical Trial

Automated Vision Assessment and Impairment Detection Through Gaze Analysis in Wet AMD Patients

Study acronym: AVIGA2
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the Automated Vision Assessment and Impairment Detection through Gaze Analysis (AVIGA) system in the ability to detect and assess central vision dysfunction in a personalized, adaptive, objective, and automated way through eye gaze tracking in age-related macular degeneration (AMD). We also aim to develop a novel algorithm / scoring methodology for disease activity monitoring over time (delta-change). AVIGA visual risk prediction cut-off scores will be presented together with probabilities of occurrence of prespecified adverse clinical outcome.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-18; most recent amendment 2026-01-05.
Trial Details
NCT Number NCT06518512
Lead Sponsor Tan Tock Seng Hospital
Collaborators: Occutrack Medical Solutions Pte Ltd
Conditions Age-Related Macular Degeneration, Wet Age-related Macular Degeneration
Enrollment 128 participants
Start Date 2023-04-18
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-08